Kinetic Medical(SZ:300326) Zheng Quan Shi Bao Wang·2025-08-06 01:36Core Viewpoint - ST凯利 plans to issue a total of 2.7 million yuan in bonuses for its senior management for the year 2024, despite significant declines in profits compared to the previous year, leading to opposition from two board members [1][2]. Group 1: Bonus Proposal - The board of ST凯利 approved a proposal to grant 2.7 million yuan in bonuses to senior management for 2024, based on their contributions to profit generation and future planning [2]. - The proposal received 5 votes in favor and 2 against, with board members 金诗强 and 狄朝平 opposing the decision due to the company's poor financial performance [2]. Group 2: Financial Performance - In 2024, ST凯利 reported a revenue of 985 million yuan, a year-on-year increase of 2.96%, but experienced a significant decline in operating profit and total profit, with losses of 107 million yuan and 110 million yuan, respectively, representing year-on-year decreases of 176.39% and 182.63% [3]. - The net profit attributable to shareholders was -106 million yuan, with a non-recurring net profit of -65.31 million yuan, reflecting year-on-year declines of 193.80% and 205.93% [3]. Group 3: Corporate Actions - ST凯利 announced plans to sell a 36.9% stake in 洁诺医疗 to 上海荟添医疗科技有限公司, as part of a strategy to exit its investment in 景正医疗 [3]. - 洁诺医疗 reported revenues of 282 million yuan and 126 million yuan for 2024 and January-May 2025, respectively, with net profits of 16.98 million yuan and 15.22 million yuan [3]. - The valuation of 洁诺医疗's total equity was assessed at 425 million yuan, with an increase of 299 million yuan, resulting in a growth rate of 237.24% [3].